Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.

Mendoza N, Galan MI, Molina C, Mendoza-Tesarik R, Conde C, Mazheika M, Diaz-Ropero MP, Fonolla J, Tesarik J, Olivares M.

Gynecol Endocrinol. 2019 Oct 26:1-4. doi: 10.1080/09513590.2019.1681959. [Epub ahead of print]

PMID:
31657275
2.

Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models.

Conde C, Escribano BM, Luque E, Feijóo M, Caballero-Villarraso J, Valdelvira ME, Ochoa-Sepúlveda JJ, Lillo R, Paz E, Santamaría A, Agüera E, Túnez I.

Nutrients. 2019 Oct 14;11(10). pii: E2448. doi: 10.3390/nu11102448.

3.

Bio-Inspired Presentation Attack Detection for Face Biometrics.

Tsitiridis A, Conde C, Gomez Ayllon B, Cabello E.

Front Comput Neurosci. 2019 May 28;13:34. doi: 10.3389/fncom.2019.00034. eCollection 2019.

4.

Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis.

Escribano BM, Aguilar-Luque M, Bahamonde C, Conde C, Lillo R, Sanchez-Lopez F, Giraldo AI, Cruz AH, Luque E, Gascon F, Aguera E, Tunez I.

Curr Pharm Des. 2016;22(31):4876-4880.

PMID:
27396595
5.

Videosensor for the detection of unsafe driving behavior in the proximity of black spots.

Fuentes A, Fuentes R, Cabello E, Conde C, Martin I.

Sensors (Basel). 2014 Oct 24;14(11):19926-44. doi: 10.3390/s141119926.

6.

Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress.

Bahamonde C, Conde C, Agüera E, Lillo R, Luque E, Gascón F, Feijóo M, Cruz AH, Sánchez-López F, Túnez I.

Eur J Pharmacol. 2014 May 5;730:26-30. doi: 10.1016/j.ejphar.2014.02.020. Epub 2014 Feb 25.

PMID:
24582759
7.

Association between smoking status and the parameters of vascular structure and function in adults: results from the EVIDENT study.

Recio-Rodriguez JI, Gomez-Marcos MA, Patino Alonso MC, Martin-Cantera C, Ibañez-Jalon E, Melguizo-Bejar A, Garcia-Ortiz L; EVIDENT Group.

BMC Cardiovasc Disord. 2013 Dec 1;13:109. doi: 10.1186/1471-2261-13-109.

8.

Electrocardiographic left ventricular hypertrophy criteria and ambulatory blood pressure monitoring parameters in adults.

Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Fernandez-Alonso C, Martinez Vizcaino V, Cantera CM, Guenaga-Saenz N, González-Viejo N, García-Ortiz L; EVIDENT Study, Spain.

Am J Hypertens. 2014 Mar;27(3):355-62. doi: 10.1093/ajh/hpt198. Epub 2013 Nov 4.

PMID:
24190901
9.

Blood pressure circadian pattern and physical exercise assessment by accelerometer and 7-day physical activity recall scale.

García-Ortiz L, Recio-Rodríguez JI, Puig-Ribera A, Lema-Bartolomé J, Ibáñez-Jalón E, González-Viejo N, Guenaga-Saenz N, Agudo-Conde C, Patino-Alonso MC, Gomez-Marcos MA; EVIDENT Group.

Am J Hypertens. 2014 May;27(5):665-73. doi: 10.1093/ajh/hpt159. Epub 2013 Aug 24.

PMID:
23975330
10.

Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.

Tasset I, Bahamonde C, Agüera E, Conde C, Cruz AH, Pérez-Herrera A, Gascón F, Giraldo AI, Ruiz MC, Lillo R, Sánchez-López F, Túnez I.

Pharmacol Rep. 2013;65(3):624-31.

11.

Combination and selection of traffic safety expert judgments for the prevention of driving risks.

Cabello E, Conde C, de Diego IM, Moguerza JM, Redchuk A.

Sensors (Basel). 2012 Nov 2;12(11):14711-29. doi: 10.3390/s121114711.

12.

Physical exercise, fitness and dietary pattern and their relationship with circadian blood pressure pattern, augmentation index and endothelial dysfunction biological markers: EVIDENT study protocol.

García-Ortiz L, Recio-Rodríguez JI, Martín-Cantera C, Cabrejas-Sánchez A, Gómez-Arranz A, González-Viejo N, Iturregui-San Nicolás E, Patino-Alonso MC, Gómez-Marcos MA; EVIDENT Group.

BMC Public Health. 2010 May 6;10:233. doi: 10.1186/1471-2458-10-233.

Supplemental Content

Loading ...
Support Center